Elite in Presbyopia

Gerd U. Auffarth

Heidelberg, BW, DE 
Elite in Presbyopia
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Gerd Auffarth practices in Heidelberg, Germany. Auffarth is rated as an Elite expert by MediFind in the treatment of Presbyopia. Their top areas of expertise are Cataract, Astigmatism, Presbyopia, Cataract Removal, and Corneal Transplant.

Their clinical research consists of co-authoring 410 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 39 articles and participated in 1 clinical trial in the study of Presbyopia.

Locations

Heidelberg, BW, Germany
Other Locations
Salem, BW, Germany
Frankfurt Am Main, HE, Germany
Ahaus, NW, Germany
Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Multicentric Post-Market Clinical Follow-up (PMCF) Investigation to Determine Safety and Efficacy of a Hydrophobic EDOF Intraocular Lens (IOL) in Comparison to a Monofocal IOL
Multicentric Post-Market Clinical Follow-up (PMCF) Investigation to Determine Safety and Efficacy of a Hydrophobic EDOF Intraocular Lens (IOL) in Comparison to a Monofocal IOL
Enrollment Status: Active_not_recruiting
Publish Date: May 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
An Interventional, Open-label, Multicenter Phase I/IIa Clinical Trial to Investigate the Safety and Efficacy of Ascending Doses of Allogeneic ABCB5-positive Limbal Stem Cells (LSC2) for the Treatment of Limbal Stem Cell Deficiency (LSCD)
An Interventional, Open-label, Multicenter Phase I/IIa Clinical Trial to Investigate the Safety and Efficacy of Ascending Doses of Allogeneic ABCB5-positive Limbal Stem Cells (LSC2) for the Treatment of Limbal Stem Cell Deficiency (LSCD)
Enrollment Status: Unknown
Publish Date: October 07, 2022
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%
A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Device, Drug
Study Drug: Travoprost
Study Phase: Phase 4
Development of a Database (Register) for Quality Assurance and Optimization of the Postoperative Results of Premium Intraocular Lenses
Development of a Database (Register) for Quality Assurance and Optimization of the Postoperative Results of Premium Intraocular Lenses
Enrollment Status: Completed
Publish Date: January 11, 2022
Intervention Type: Device
Study Phase: Not Applicable
Clinical Evaluation of the FluidVision Accommodating Intraocular Lens
Clinical Evaluation of the FluidVision Accommodating Intraocular Lens
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
View 4 Less Clinical Trials

410 Total Publications

Optical Differentiation of Presbyopia-Correcting Intraocular Lenses With Improved Intermediate Vision From a Single Manufacturer.
Optical Differentiation of Presbyopia-Correcting Intraocular Lenses With Improved Intermediate Vision From a Single Manufacturer.
Journal: Journal of refractive surgery (Thorofare, N.J. : 1995)
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Auffarth's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 17 Advanced Conditions
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile